LEADER 03334nam 22004695 450 001 9910855386303321 005 20250807140239.0 010 $a9789819703579 024 7 $a10.1007/978-981-97-0357-9 035 $a(CKB)31801402000041 035 $a(MiAaPQ)EBC31308619 035 $a(Au-PeEL)EBL31308619 035 $a(DE-He213)978-981-97-0357-9 035 $a(MiAaPQ)EBC31574339 035 $a(Au-PeEL)EBL31574339 035 $a(OCoLC)1432821928 035 $a(EXLCZ)9931801402000041 100 $a20240426d2024 u| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRising China and Internet Governance $eMultistakeholderism, Fragmentation and the Liberal Order in the Age of Digital Sovereignty /$fby Riccardo Nanni 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Palgrave Macmillan,$d2024. 215 $a1 online resource (216 pages) 311 08$a9789819703562 327 $a1. Introduction -- 2. China, Internet Governance, and the Liberal International Order -- 3. Situating Chinese engagement in Internet governance: China?s domestic digital policy reviewed -- 4. On the Normative Impact of Chinese Stakeholders in the Governance of Critical Internet Resources. A Document- and Interview-based Analysis -- 5. On the Normative Impact of Chinese Stakeholders in Mobile Internet Standard-making. A Document- and Interview-based Analysis -- 6. The Rise of China, Internet Fragmentation, and the Future of Multistakeholderism: Implications for the Liberal International Order -- 7. Conclusion. 330 $aThis book provides an account of the transformation of Chinese stakeholders' engagement in Internet governance, from normative contestation to integration, and from isolation to an industrial leadership role. The book concludes that Chinese stakeholders are not seeking to fragment the Internet but are rather integrating in the existing global Internet governance mechanisms while adopting strong regulation domestically. This counters a widespread media (and academic) narrative on China as the promoter of an alternative Internet and/or an alternative model of Internet governance. These conclusions are reached through a mix of qualitative methods, including interviews with people involved first-hand in Internet governance, such as technologists engaged in the making of Internet and mobile connectivity standards. Riccardo Nanni is Researcher in Data Governance at Fondazione Bruno Kessler's Digital Commons Lab. He obtained a Ph.D. in International Relations (June 2022) from the Department of Political and Social Sciences of the University of Bologna (Italy). His Ph.D. thesis discussed the influence of Chinese public and private stakeholders in Internet governance, particularly the making and distribution of Internet and mobile connectivity standards. 606 $aPolitical science 606 $aGovernance and Government 615 0$aPolitical science. 615 14$aGovernance and Government. 676 $a320.4 700 $aNanni$b Riccardo$01437349 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910855386303321 996 $aRising China and Internet Governance$94160112 997 $aUNINA LEADER 03932nam 2201309z- 450 001 9910566482503321 005 20220506 035 $a(CKB)5680000000037555 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81038 035 $a(oapen)doab81038 035 $a(oapen)81038 035 $a(EXLCZ)995680000000037555 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aThe Role of PPARs in Disease 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (274 p.) 311 08$a3-0365-3992-1 311 08$a3-0365-3991-3 330 $aThis reprint combines recent original manuscripts and reviews covering the multiple functions of peroxisome proliferator-activated receptors in physiology and pathophysiology. Potential applications and limitations of PPAR agonists and antagonists are discussed. All original contributions were published in Cells. 606 $aMedicine and Nursing$2bicssc 606 $aPhysiology$2bicssc 610 $aaddiction 610 $aadipogenesis 610 $aAKI 610 $aalcohol 610 $aAlzheimer's 610 $aAlzheimer's disease (AD) 610 $aangiogenesis 610 $aanimal models 610 $acancer 610 $acellular metabolism 610 $acilia 610 $aCKD 610 $acognition 610 $acoronary artery 610 $aCYP450 610 $acystogenesis 610 $adominant-negative isoform 610 $aeicosanoids 610 $aendothelial cells 610 $afatty acids 610 $afetal programming 610 $afibrosis 610 $afolate 610 $agrowth suppressors 610 $ahuman studies 610 $ahypertrophic adipocytes 610 $ahypertrophic obesity 610 $aimmortality 610 $aimmune system 610 $ain vitro adipocytes 610 $ainflammation 610 $ainherited metabolic disorders 610 $ainsulin-resistance 610 $akidney 610 $aligand 610 $aligands 610 $alipidomics 610 $alipids 610 $ametabolic syndrome 610 $ametastasis 610 $ametastasis formation 610 $amodulators 610 $anephron 610 $anicotine 610 $anon-alcoholic fatty liver disease (NAFLD) 610 $anon-alcoholic steatohepatitis (NASH) 610 $anuclear receptors 610 $aobesity 610 $aopioids 610 $aperoxisome proliferator activated receptors 610 $aperoxisome proliferator-activated receptor 610 $aperoxisome proliferator-activated receptor-? coactivator-1? 610 $aperoxisome proliferator-activated receptors (PPARs) 610 $aperoxisome-proliferator activated receptors 610 $aPGC-1?, disease 610 $apharmacology 610 $aPKD 610 $aPPAR 610 $aPPARG isoforms 610 $aPPARG splicing 610 $aPPARs 610 $aPPAR? 610 $aproliferation 610 $apsychostimulants 610 $aresistance to cell death 610 $arisk factors 610 $aRNA sequencing 610 $asex 610 $aSirtuin1 610 $asynthetic agonists 610 $atherapy 610 $atoxicology 610 $atumor angiogenesis 610 $atumor progression 610 $avascular 610 $avitamin B12 615 7$aMedicine and Nursing 615 7$aPhysiology 700 $aWagner$b Nicole$4edt$01303406 702 $aWagner$b Kay-Dietrich$4edt 702 $aWagner$b Nicole$4oth 702 $aWagner$b Kay-Dietrich$4oth 906 $aBOOK 912 $a9910566482503321 996 $aThe Role of PPARs in Disease$93027006 997 $aUNINA